Why current scores miss the mark
For years, scientists tested genetic scores on huge groups. They looked at averages. This hid the truth about single patients.
A new study asks a harder question. Can these scores actually find the right people? The answer reveals a big gap.
Researchers found a disconnection between big numbers and real life. A score might look great on paper. But it fails for specific patients.
This matters because we want to help the right people first. We cannot waste time on tools that do not work. Precision is key for safety.
Think of a genetic score like a fishing net. Old nets were too big. They caught fish but missed the specific ones you wanted.
This study built a better net. It focused on a specific group: young people with heart disease but no other risk factors.
These patients had low cholesterol and no diabetes. Yet they still got heart disease early. This makes them the perfect group to test against.
Using this group creates a "ground truth". If a score misses them, it failed the test. This is a strict standard for accuracy.
What the researchers tested
The team looked at 1,184 patients. These were early-onset cases with low clinical risk. They tested 58 different genetic scores against this group.
This group served as a benchmark. If a score missed them, it failed the test. This is a strict standard for accuracy.
The surprising results
The scores performed very differently. Some caught only 10% of the patients. The best one caught 33%.
This means most patients were missed by the top tools. Even the best score was twice as good as standard blood markers like lipoprotein(a).
This shows genetics can be powerful. But it is not perfect yet. We are still learning how to use it.
This doesn’t mean this treatment is available yet.
Why some people were missed
Some patients were never caught by any score. These people had healthier lipid profiles. This suggests genetics is not the only factor.
Other factors might be at play here. Environment and lifestyle still matter a lot. Genes are just one piece of the puzzle.
Experts say this helps us understand where genetic testing stands today. It shows we need better tools before using them in clinics.
We cannot simply trust a number from a lab. The science is still evolving rapidly. We must wait for more proof.
You cannot order this test at home right now. It is still in research. Talk to your doctor about your personal risk factors.
Ask about your family history and lifestyle choices. These remain the most reliable ways to lower risk today.
What we still do not know
This study is a preprint. It has not been peer-reviewed by a major journal yet. The group size is also relatively small.
We do not know if this works for everyone. It was tested on a specific type of patient. Results may vary for others.
What happens next in research
Researchers need to test this on larger groups. They must prove it works before doctors can use it. Real-world approval takes time.
Future trials will check if these scores help prevent disease. We hope to see better tools soon. But patience is key for safety.
